Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4758982
Max Phase: Preclinical
Molecular Formula: C71H124F2N10O6S2
Molecular Weight: 1315.97
Molecule Type: Unknown
Associated Items:
ID: ALA4758982
Max Phase: Preclinical
Molecular Formula: C71H124F2N10O6S2
Molecular Weight: 1315.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCCSCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)C1(NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cc(F)cc(F)c2)NC(=O)[C@@H](N)CSCCCCCCCCCCCCCCCCCC)CCC1
Standard InChI: InChI=1S/C71H124F2N10O6S2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-48-90-50-45-77-65(85)62-40-36-46-82(62)67(87)60(39-35-44-78-70(75)76)80-69(89)71(42-38-43-71)81-66(86)63-41-37-47-83(63)68(88)61(53-56-51-57(72)54-58(73)52-56)79-64(84)59(74)55-91-49-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h51-52,54,59-63H,3-50,53,55,74H2,1-2H3,(H,77,85)(H,79,84)(H,80,89)(H,81,86)(H4,75,76,78)/t59-,60-,61-,62-,63-/m0/s1
Standard InChI Key: FLEHNZHPKJVWGD-DYYFIOKNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1315.97 | Molecular Weight (Monoisotopic): 1314.9115 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Micewicz ED,Nguyen C,Micewicz A,Waring AJ,McBride WH,Ruchala P. (2019) Position of lipidation influences anticancer activity of Smac analogs., 29 (13): [PMID:31047753] [10.1016/j.bmcl.2019.04.041] |
Source(1):